Drugs / BOL-DP-o-08
last change Dec 2020 re-read 3 minutes ago

BOL-DP-o-08

Developed for
endometriosis
Investigated by
Breath of Life International Pharma Ltd

Trials 1

20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT04174911 Jan 2019 → Dec 2020 endometriosis Breath of Life International Pharma Ltd Withdrawn No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BOL-DP-o-08 ClinicalTrials.gov intervention name — accepted as the source's own label NCT04174911 ↗
Route Other “sublingual drops” NCT04174911 ↗